Our clinicians will be able to help you decide what is best for your circumstances
"Both medications are excellent options for managing type 2 diabetes, but the choice between tirzepatide and semaglutide will depend on the patient's specific needs, weight management goals, and response to other therapies," says Candice Sapp, RD
The production of synaptophysin and SNAP-25, two proteins that contribute to synaptic formation and neurotransmitter release, has been discovered to be decreased by UCB
Adjust portions based on your specific weight and tolerance
manufacturing facility to boost GLP-1 drug output Novo Nordisk announced a $4.1 billion investment to build a new manufacturing facility in North Carolina, aiming to increase production capacity for its GLP-1-based diabetes and obesity drugsamid surging demand
Losing weight can be an arduous process